Sale deal for cancer firm

Share this article
Have your say

A CANCER research firm founded 13 years ago by a former Edinburgh University student in her bedroom has been sold to a US company in what is thought to be a multi-million pound deal.

Nexus Oncology, which is based in the Roslin Biocentre and employs more than 120 staff across Europe and North America, has been acquired by Ockham in a cash and shares deal for an undisclosed sum.

Founder and chief executive Clare Wareing will become chief scientific officer of the enlarged company, which will be led by Ockham chief executive James Baker.